Therapeutic targeting of chemokine interactions in atherosclerosis - PubMed (original) (raw)

Review

doi: 10.1038/nrd3048.

Affiliations

Review

Therapeutic targeting of chemokine interactions in atherosclerosis

Rory R Koenen et al. Nat Rev Drug Discov. 2010 Feb.

Abstract

Atherosclerosis is a chronic inflammatory disease of the arterial wall that is characterized by a disturbed equilibrium of immune responses and lipid accumulation, leading to the development of plaques. The atherogenic influx of mononuclear cells is orchestrated by chemokines and their receptors. Studies using gene-deficient mice and antagonists based on peptides and small molecules have generated insight into targeting chemokine-receptor axes for treating atherosclerosis, which might complement lipid-lowering strategies and risk factor modulation. Combined inhibition of multiple chemokine axes could interfere with the contributions of chemokines to disease progression at specific cells, stages or sites. In addition, the recently characterized heterophilic interactions of chemokines might present a novel target for the treatment and prevention of inflammatory diseases such as atherosclerosis.

PubMed Disclaimer

References

    1. Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1858-63 - PubMed
    1. Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):251-7 - PubMed
    1. Science. 1994 Apr 1;264(5155):90-2 - PubMed
    1. Nat Med. 2009 Jan;15(1):97-103 - PubMed
    1. J Clin Invest. 2007 Mar;117(3):616-26 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources